Rua Life Sciences PLC
RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast… Read more
Rua Life Sciences PLC (RUA) - Total Assets
Latest total assets as of September 2025: GBX9.12 Million GBX
Based on the latest financial reports, Rua Life Sciences PLC (RUA) holds total assets worth GBX9.12 Million GBX as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Rua Life Sciences PLC - Total Assets Trend (1994–2025)
This chart illustrates how Rua Life Sciences PLC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Rua Life Sciences PLC - Asset Composition Analysis
Current Asset Composition (March 2025)
Rua Life Sciences PLC's total assets of GBX9.12 Million consist of 58.5% current assets and 41.5% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 38.5% |
| Accounts Receivable | GBX1.09 Million | 11.8% |
| Inventory | GBX754.00K | 8.2% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX375.00K | 4.1% |
| Goodwill | GBX301.00K | 3.3% |
Asset Composition Trend (1994–2025)
This chart illustrates how Rua Life Sciences PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Rua Life Sciences PLC's current assets represent 58.5% of total assets in 2025, an increase from 49.2% in 1994.
- Cash Position: Cash and equivalents constituted 38.5% of total assets in 2025, up from 0.1% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, a decrease from 19.0% in 1994.
- Asset Diversification: The largest asset category is accounts receivable at 11.8% of total assets.
Rua Life Sciences PLC Competitors by Total Assets
Key competitors of Rua Life Sciences PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Rua Life Sciences PLC - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Rua Life Sciences PLC generates 0.44x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Rua Life Sciences PLC generates $ 0.01 in net profit.
Rua Life Sciences PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.64 | 6.47 | 1.67 |
| Quick Ratio | 3.87 | 5.25 | 1.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX4.23 Million | GBX 5.00 Million | GBX 561.00K |
Rua Life Sciences PLC - Advanced Valuation Insights
This section examines the relationship between Rua Life Sciences PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.16 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 13.3% |
| Total Assets | GBX9.26 Million |
| Market Capitalization | $1.01K USD |
Valuation Analysis
Below Book Valuation: The market values Rua Life Sciences PLC's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Rua Life Sciences PLC's assets grew by 13.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Rua Life Sciences PLC (1994–2025)
The table below shows the annual total assets of Rua Life Sciences PLC from 1994 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | GBX9.26 Million | +13.29% |
| 2024-03-31 | GBX8.17 Million | +44.25% |
| 2023-03-31 | GBX5.66 Million | -25.74% |
| 2022-03-31 | GBX7.63 Million | -24.90% |
| 2021-03-31 | GBX10.15 Million | +307.18% |
| 2020-03-31 | GBX2.49 Million | -19.52% |
| 2019-03-31 | GBX3.10 Million | +186.15% |
| 2018-03-31 | GBX1.08 Million | -4.44% |
| 2017-03-31 | GBX1.13 Million | -15.16% |
| 2016-03-31 | GBX1.34 Million | -24.91% |
| 2015-03-31 | GBX1.78 Million | -8.76% |
| 2014-03-31 | GBX1.95 Million | -36.30% |
| 2013-03-31 | GBX3.06 Million | -14.16% |
| 2012-03-31 | GBX3.57 Million | -5.71% |
| 2011-03-31 | GBX3.78 Million | -37.34% |
| 2010-03-31 | GBX6.04 Million | -10.22% |
| 2009-03-31 | GBX6.72 Million | -14.27% |
| 2008-03-31 | GBX7.84 Million | +113.27% |
| 2007-03-31 | GBX3.68 Million | -36.16% |
| 2006-03-31 | GBX5.76 Million | -4.02% |
| 2005-03-31 | GBX6.00 Million | -25.03% |
| 2004-03-31 | GBX8.01 Million | -13.37% |
| 2003-03-31 | GBX9.24 Million | -81.08% |
| 2002-03-31 | GBX48.84 Million | +26.92% |
| 2001-03-31 | GBX38.48 Million | -13.27% |
| 2000-03-31 | GBX44.37 Million | +717.20% |
| 1999-03-31 | GBX5.43 Million | +39.10% |
| 1998-03-31 | GBX3.90 Million | -16.28% |
| 1997-03-31 | GBX4.66 Million | +125.87% |
| 1996-03-31 | GBX2.06 Million | +6.17% |
| 1995-03-31 | GBX1.94 Million | -6.49% |
| 1994-03-31 | GBX2.08 Million | -- |